Citadel Advisors’s PolyPid PYPD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-257
Closed -$5.37K 15343
2022
Q4
$5.37K Sell
257
-236
-48% -$6.1K ﹤0.01% 14008
2022
Q3
$17K Sell
493
-1,964
-80% -$243K ﹤0.01% 12133
2022
Q2
$342K Buy
2,457
+1,310
+114% +$196K ﹤0.01% 9512
2022
Q1
$188K Buy
+1,147
New +$174K ﹤0.01% 11613

Other funds holding PYPD

Citadel Advisors's PYPD Position: Q1 2026 in Review

Citadel Advisors increased its PolyPid (PYPD) stake by 439% in Q1 2026, buying an estimated $208K and bringing the position to 57,769 shares worth $253K. The position accounts for ﹤0.01% of the portfolio, ranked #10881.

Citadel Advisors first reported a position in PYPD in Q2 2020 and has held it in 11 quarters since. The position peaked at $1.65M in Q2 2020. 19 funds tracked by Wall St. Rank hold PYPD as of Q1 2026.

  • Citadel Advisors held 57,769 shares of PolyPid worth $253K as of Q1 2026.
  • Citadel Advisors bought 47,046 PolyPid shares in Q1 2026, an estimated $208K.
  • PolyPid made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #10881 holding.
  • Citadel Advisors first reported a position in PolyPid in Q2 2020 and has held it in 11 quarters since.
  • Citadel Advisors's PolyPid position peaked at $1.65M in Q2 2020.
  • 19 funds tracked by Wall St. Rank held PolyPid as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.